Human papillomavirus molecular testing in women with low grade cervical lesions: Experience from an Italian Hospital

Anticancer Research

Volumn 32, Issue 4, 2012, Pages 1253-1257

  Paba, Pierpaolo ^a   Ascone, Chiara ^a   Criscuolo, Anna Angela ^a   Marcuccilli, Fabbio ^a   Ciccozzi, Massimo ^b   Sesti, Francesco ^a   Piccione, Emilio ^a   Perno, Carlo Federico ^a,c   Ciotti, Marco ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

HPV; HPV DNA test; HPV E6 E7 transcripts; HPV RNA testing

Indexed keywords

ARTICLE; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; FEMALE; HOSPITAL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MIXED INFECTION; ONCOGENE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; WART VIRUS;

ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; ITALY;

EID: 84859978216     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543, 2001.
2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Muñoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999. (Pubitemid 29406813)
3. Bernard HU, Burk RD, Chen Z, van DK, Hausen H and de Villiers EM: Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virol 401: 70-79, 2010.
4. Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsague X, Shah KV, Snijders PJ and Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
5. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N and Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7: 453-459, 2007. (Pubitemid 46962343)
6. Moscicki AB, Schiffman M, Kjaer S and Villa LL: Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 24S3: S3/42-51, 2006.
7. Werness BA, Levine AJ and Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79, 1990.
8. Dyson N, Howley PM, Munger K and Harlow E: The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-936, 1989.
9. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D and Goldie SJ: Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst 98: 92-100, 2006. (Pubitemid 43159963)
10. Rebolj M, Bais AG, van Ballegooijen M, Boer R, Meerding W-J, Heimerhorst TJM and Habbema JDF: Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies. Int J Cancer 121: 1529-1535, 2007. (Pubitemid 47328712)
11. Castle PE, Solomon D, Schiffman M, Wheeler CM: Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Nation Cancer Inst 97: 1066-1071, 2005. (Pubitemid 41417923)
12. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F and Franco EL: Human papillomavirus and Papanicolau tests to screen for cervical cancer. N Engl J Med 357: 1579-1588, 2007. (Pubitemid 47598400)
13. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Forslund O, Hansson B-G, Rylander E and Dillner J: Human papillomavirus and Papanicolau tests to screen for cervical cancer. N Engl J Med 357: 1589-1597, 2007. (Pubitemid 47598401)
14. Ho GY, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423-428, 1998. (Pubitemid 28135669)
15. Molden T, Kraus I, Karlsen F, Skomedal H, Nygård JF and Hagmar B: Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women 30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 14: 367-372, 2005. (Pubitemid 40270098)
16. Molden, T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, and Hagmar B: Predicting CIN2 when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear. Int J Cancer 114: 973-976, 2005.
17. Cattani P, Siddu A, D'Onghia S, Marchetti S, Santangelo R, Vellone VG, Zannoni GF and Fadda G: RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 47: 2136-2141, 2009.
18. Cattani P, Zannoni GF, Ricci C, D'Onghia S, Trivellizzi IN, Di Franco A, Vellone VG, Durante M, Fadda G, Scambia G, Capelli G and De Vincenzo R: Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 47: 3895-3901, 2009.
19. Sørbye SW, Fismen S, Gutteberg T, Mortensen ES. Triage of women with minor cervical lesions: data suggesting a 'Test and Treat' approach for HPV E6/E7 mRNA testing. Plos One 5: e12724, 2010.
20. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr., Young N for the Forum Group Members and the Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287: 2114-2119, 2002. (Pubitemid 34437346)
21. Moscicki AB, Shiboski S, Hills NK, Powel KI, Jai N, Hanson EN, Miller S, Canjura-Clayton LK, Farhat S, Broering JM and Darragh TM: Regression of low-gade squamous intra-epithelial lesion in young women. Lancet 364: 1678-1683, 2004. (Pubitemid 39458143)
22. Lie KA and Kristensen G: Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 8: 405-415, 2008.
23. Trope A, Sjøborg K, Eskild A, Cuschieri K, Eriksen T, Thoresen S, Steinbakk M, Laurak V, Jonassen CM, Westerhagen U, Jacobsen MB and Lie AK: Performance of human DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 47: 2458-2464, 2009.
24. Waldstrom M and Ornskov D: Comparison of the clinical performance of an HPV mRNA test and an HPV-DNA test in triage of atypical squamous cells of undetermined significance (ASC-US). Cytopathology, 2011 [Epub ahead of print].